[1] 康治理, 刘晓伟, 武振方, 等. 基于生物信息学分析的骨肉瘤关键生物标记物的筛选[J]. 蚌埠医学院学报, 2022, 47(3): 386. doi: 10.13898/j.cnki.issn.1000-2200.2022.03.028
[2] WAN Y, QU N, YANG Y, et al. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients[J]. Bioengineered, 2021, 12(1): 5916. doi: 10.1080/21655979.2021.1971919
[3] 杨楠, 陈天翔, 刘润坤, 等. 长链非编码RNA LINC00319在肝细胞癌中表达上调并促进肝癌细胞迁移和侵袭[J]. 蚌埠医学院学报, 2022, 47(2): 152.
[4] 杨硕, 陈天天, 王文锐, 等. 长链非编码RNA LINC00173在紫杉醇耐药乳腺癌细胞中的作用[J]. 蚌埠医学院学报, 2020, 45(9): 1153.
[5] DING L, LIU T, QU Y, et al. lncRNA MELTF-AS1 facilitates osteosarcoma metastasis by modulating MMP14 expression[J]. Mol Ther Nucleic Acids, 2021, 26(1): 787.
[6] WANG C, ZHANG T, YANG L, et al. LncRNA BACE1-AS promotes the progression of osteosarcoma through miR-762/SOX7 axis[J]. Mol Biol Rep, 2022, 49(7): 5853. doi: 10.1007/s11033-022-07364-7
[7] YANG W, WANG X, SONG S, et al. Long noncoding RNA ALOX12-AS1 inhibits cervical cancer cells proliferation via targeting miR-3171[J]. Anticancer Drugs, 2022, 33(1): e362. doi: 10.1097/CAD.0000000000001214
[8] MAY-HAU DI, BÁRCENAS-LÓPEZ DA, NÚÑEZ-ENRÍQUEZ JC, et al. Underexpression of LINC00173 in TCF3/PBX1-positive cases is associated with poor prognosis in children with B-cell precursor acute lymphoblastic leukemia[J]. Front Oncol, 2022, 12(1): 887766.
[9] ZHANG Y, ZHANG X, ZHU H, et al. Identification of potential prognostic long non-coding RNA biomarkers for predicting recurrence in patients with cervical cancer[J]. Cancer Manag Res, 2020, 12(1): 719.
[10] CHEN J, LIU A, WANG Z, et al. LINC00173. v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression[J]. Mol Cancer, 2020, 19(1): 98. doi: 10.1186/s12943-020-01217-2
[11] 潘海霞, 杨兰, 胡洪林, 等. lncRNA NCRNA00173在骨肉瘤组织中的表达及其临床意义[J]. 中国肿瘤生物治疗杂志, 2017, 24(8): 884.
[12] VIMALRAJ S, SUBRAMANIAN R, DHANASEKARAN A. LncRNA MALAT1 promotes tumor angiogenesis by regulating microRNA-150-5p/VEGFA signaling in osteosarcoma: in-vitro and in-vivo analyses[J]. Front Oncol, 2021, 11(1): 742789.
[13] ZHAO A, ZHAO Z, LIU W, et al. Carcinoma-associated fibroblasts promote the proliferation and metastasis of osteosarcoma by transferring exosomal LncRNA SNHG17[J]. Am J Transl Res, 2021, 13(9): 10094.
[14] ZHANG H, LIU S, TANG L, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9)[J]. Bioengineered, 2021, 12(1): 162. doi: 10.1080/21655979.2020.1863014
[15] YANG Q, TANG Y, TANG C, et al. Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-κB pathway in non-small-cell lung cancer[J]. Am J Transl Res, 2019, 11(7): 4248.
[16] ZENG F, WANG Q, WANG S, et al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression[J]. Oncogene, 2020, 39(2): 293. doi: 10.1038/s41388-019-0984-2
[17] YANG F, LEI P, ZENG W, et al. Long noncoding RNA LINC00173 promotes the malignancy of melanoma by promoting the expression of IRS4 through competitive binding to microRNA-493[J]. Cancer Manag Res, 2020, 12(1): 3131.
[18] ZHANG J, ZHOU M, ZHAO X, et al. Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis[J]. Pathol Res Pract, 2020, 1(1): 152994.
[19] FAN H, YUAN J, LI X, et al. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression[J]. Biomed Pharmacother, 2020, 125(1): 109987.
[20] ZHANG H, SONG J. Knockdown of lncRNA C5orf66-AS1 inhibits osteosarcoma cell proliferation and invasion via miR-149-5p upregulation[J]. Oncol Lett, 2021, 22(5): 757. doi: 10.3892/ol.2021.13018
[21] CHEN J, YAN D, WU W, et al. MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN[J]. Oncol Rep, 2016, 35(6): 3285. doi: 10.3892/or.2016.4719